Dishman Carbogen Amcis Limited

NSEI:DCAL Rapport sur les actions

Capitalisation boursière : ₹34.5b

Dishman Carbogen Amcis Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Dishman Carbogen Amcis.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Life Sciences croissance des bénéfices22.8%
Taux de croissance des recettesn/a
Rendement futur des capitaux propresn/a
Couverture par les analystes

None

Dernière mise à journ/a

Mises à jour récentes de la croissance future

Recent updates

The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Oct 15
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Jun 01
Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Feb 25
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 29
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Jun 22
Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Feb 14
Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Jun 22
Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

May 18
Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

Mar 14
Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Aug 23
We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Apr 29
Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

Mar 16
Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

Feb 23
A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Feb 05
How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

Jan 23
Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Jan 10
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dec 23
Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 05
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Nov 17
Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

Oct 23
If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Sep 27
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Sep 06
Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Aug 03
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Jul 20
Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Jul 06
Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Dishman Carbogen Amcis n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

NSEI:DCAL - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
9/30/202426,186-1,740-3862,244N/A
6/30/202424,162-2,480N/AN/AN/A
3/31/202426,158-1,5348073,840N/A
12/31/202325,796-1,542N/AN/AN/A
9/30/202325,683-477-8623,388N/A
6/30/202325,957-168N/AN/AN/A
3/31/202324,129-298-3,5372,660N/A
12/31/202223,634-37N/AN/AN/A
9/30/202222,856-152-3,3832,082N/A
6/30/202221,30660N/AN/AN/A
3/31/202221,407180-1,0893,549N/A
12/31/202121,013-724N/AN/AN/A
9/30/202120,078-1,2399465,777N/A
6/30/202119,884-1,277N/AN/AN/A
3/31/202119,120-1,6511,4665,127N/A
12/31/202018,946419N/AN/AN/A
9/30/202019,6839082,8485,893N/A
6/30/202019,9611,246N/AN/AN/A
3/31/202020,4361,5851,7665,851N/A
12/31/201921,8121,837N/AN/AN/A
9/30/201921,1792,022N/AN/AN/A
6/30/201920,9832,050N/AN/AN/A
3/31/201920,5862,103-2612,820N/A
12/31/201818,9241,862N/AN/AN/A
9/30/201818,7451,768N/AN/AN/A
6/30/201818,8261,812N/AN/AN/A
3/31/201816,9481,546N/A2,265N/A
12/31/201717,8541,537N/AN/AN/A
9/30/201716,8401,383N/AN/AN/A
6/30/201716,7781,282N/AN/AN/A
3/31/201717,1941,454N/A3,026N/A
12/31/201612,038953N/AN/AN/A
3/31/2016689N/A15N/A
3/31/2015N/A-5N/A-13N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de DCAL est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de DCAL devraient croître plus rapidement que le marché Indian

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de DCAL devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de DCAL devraient croître plus rapidement que le marché Indian.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de DCAL devraient croître plus rapidement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de DCAL devrait être élevé dans 3 ans


Découvrir les entreprises en croissance